Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms.

One year of treatment with either of two strong blood-thinning medications—ticagrelor and prasugrel—by people with type 1 or ...

Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat ...

Obesity isn’t a moral failing; it’s what happens when humans evolved for scarcity encounter permanent abundance. When you ...

The grant from the National Institute of Diabetes and Digestive and Kidney Diseases will enable Dr. Luc Teyton and his lab to ...

While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...

The growing burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been a major driver of demand for ...

Auroras could be visible — especially in darker, rural areas — in Alaska, Washington, Oregon, Idaho, Montana, Wyoming, North Dakota, South Dakota, Nebraska, Minnesota, Iowa, Michigan, Wisconsin, New ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

A recent report found promising results associated with the impact of intermittent fasting on Type 2 diabetics. Here's what ...